Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
APOA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HIST1H1T - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNB1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHAC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GJB5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PROX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00656 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NTRK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB8B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OTUD7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MUC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GCNT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOC4-APOC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on